Comparable stake leader
Jonathan M. Cohen
SEC ownership of 20/20 Biolabs, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001139685.
Disclosed value leader
Cresset Asset Management, LLC
Comparable rows
18/24
Latest evidence
30 Jun 2026
- Public ticker
- AIDX on Nasdaq
- Parsed ownership sources
-
3/4/5, 13D/G, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Jonathan M. Cohen
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
18 of 24
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Jonathan M. Cohen
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001139685
- Issuer location
- Rockville, MD
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of 20/20 Biolabs, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Jonathan M. Cohen
Disclosed value leader
Cresset Asset Management,...
Comparable rows
18/24
Latest evidence
30 Jun 2026
3/4/5
13D/G
13F
Lead comparable stake: 17%
6 rows are not safely comparable across share classes.
13D/G row: Jonathan M. Cohen
Showing 1-8 of 24 holder rows.
Quick read
Jonathan M. Cohen leads the comparable SEC ownership view at 17%.
18 of 24 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Jonathan M. Cohen's linked filing trail.
Comparable ownership
Top 5
Jonathan M. Cohen
17%
Streeterville Capital LLC
9.9%
Full Succeed International Ltd
6.3%
Cresset Asset Management, LLC
2.3%
HRT FINANCIAL LP
0.86%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 24 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Jonathan M. Cohen |
3/4/5
13D/G
Chief Executive Officer, Director, 10%+ Owner
|
17%
from 13D/G
|
—
1,719,336 shares
mixed-class rows
|
— | 03 Mar 2026 |
| Streeterville Capital LLC |
13D/G
|
9.9%
|
—
543,680 shares
|
$0 | 25 Feb 2026 |
| Full Succeed International Ltd |
13D/G
Full Succeed International Limited
|
6.3%
|
—
651,465 shares
|
$0 | 19 Feb 2026 |
| Cresset Asset Management, LLC |
13F
Company
|
2.3%
|
$131,995
240,122 shares
|
— | 30 Jun 2026 |
| HRT FINANCIAL LP |
13F
Company
|
0.86%
|
$49,000
89,273 shares
|
— | 30 Jun 2026 |
| VANGUARD FIDUCIARY TRUST CO |
13F
Company
|
0.5%
|
$28,648
52,087 shares
|
— | 30 Jun 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.48%
|
$27,012
49,141 shares
|
— | 30 Jun 2026 |
| Atlantic Union Bankshares Corp |
13F
Company
|
0.34%
|
$19,294
35,099 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 23 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-10 of 10 reporting-owner rows connected to 20/20 Biolabs, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
10
Largest Forms 3/4/5 holder
Prasanth Reddy
Net 12M change
$0
Latest report
02 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Prasanth Reddy | Director | Mixed | 17 Feb 2026 | |||
| Ron Baker | Chief Business Officer | Mixed | 17 Feb 2026 | |||
| Michael Saul Lebowitz | Chief Scientific Officer | Mixed | 17 Feb 2026 | |||
| Richard M. Cohen | Director | Mixed | 19 Feb 2026 | |||
| John G. Compton | Director | Mixed | 19 Feb 2026 | |||
| Michael A. Ross | Director | Mixed | 19 Feb 2026 | |||
| Jiming Zhou | Chief Operating Officer | Mixed | 02 Apr 2026 | |||
| Alan B. Bergman | Chief Financial Officer | Mixed | 02 Apr 2026 | |||
| Jonathan M. Cohen | Chief Executive Officer, Director, 10%+ Owner | Mixed | 03 Mar 2026 | |||
| John W. Rollins | Director | Mixed | 19 Feb 2026 |
Recent insider transactions for 20/20 Biolabs, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alan B. Bergman | AIDX | Stock Option | Award | 100,000 | 100,000 | 02 Apr 2026 | Direct | |||
| Jiming Zhou | AIDX | Stock Option | Award | 150,000 | 150,000 | 02 Apr 2026 | Direct | |||
| Jonathan M. Cohen | Stock Option | Award | 352,936 | 352,936 | 03 Mar 2026 | Direct | ||||
| John W. Rollins | Common Stock | Conversion of derivative security | 172.5% | 19,164 | 30,275 | 19 Feb 2026 | Direct | |||
| John W. Rollins | Series A-2 Preferred Stock | Conversion of derivative security | -100% | -6,135 | 0 | 19 Feb 2026 | Direct | |||
| John W. Rollins | Series A Preferred Stock | Conversion of derivative security | -100% | -13,029 | 0 | 19 Feb 2026 | Direct | |||
| Michael A. Ross | Common Stock | Conversion of derivative security | 31 | 31 | 19 Feb 2026 | Direct | ||||
| Michael A. Ross | Series A-2 Preferred Stock | Conversion of derivative security | -100% | -31 | 0 | 19 Feb 2026 | Direct | |||
| John G. Compton | Common Stock | Conversion of derivative security | 115% | 7,669 | 14,335 | 19 Feb 2026 | Direct | |||
| John G. Compton | Series A-2 Preferred Stock | Conversion of derivative security | -100% | -7,669 | 0 | 19 Feb 2026 | Direct | |||
| Richard M. Cohen | Common Stock | Conversion of derivative security | 7,700 | 7,700 | 19 Feb 2026 | Direct | ||||
| Richard M. Cohen | Series A-2 Preferred Stock | Conversion of derivative security | -100% | -7,700 | 0 | 19 Feb 2026 | Direct |
* marks a reported price that did not pass the local price check.